NCT02489487View on ClinicalTrials.gov

Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
HIV-infection
Interventions
DRUG

VM-1500

VM-1500 40 mg

DRUG

Darunavir

Darunavir 600 mg

DRUG

Ritonavir

Ritonavir 100 mg

DRUG

Raltegravir

400 mg Raltegravir

Trial Locations (1)

10700

Faculty of Medicine, Siriraj Hospital, Bangkok

Sponsors

Lead Sponsor

Viriom
All Listed Sponsors
lead

Viriom

INDUSTRY